Progress towards a vaccine to prevent sexual transmission of HIV

被引:13
作者
Miller, CJ [1 ]
McGhee, JR [1 ]
机构
[1] UNIV ALABAMA,DEPT MICROBIOL,MUCOSAL IMMUNIZAT RES GRP,BIRMINGHAM,AL 35294
关键词
D O I
10.1038/nm0796-751
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:751 / 752
页数:2
相关论文
共 12 条
[1]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[2]   T-CELL PROLIFERATION TO SUBINFECTIOUS SIV CORRELATES WITH LACK OF INFECTION AFTER CHALLENGE OF MACAQUES [J].
CLERICI, M ;
CLARK, EA ;
POLACINO, P ;
AXBERG, I ;
KULLER, L ;
CASEY, NI ;
MORTON, WR ;
SHEARER, GM ;
BENVENISTE, RE .
AIDS, 1994, 8 (10) :1391-1395
[3]   SUPPRESSION OF ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT BY CD8(+) T-CELLS IS NOT LENTIVIRUS SPECIFIC [J].
COPELAND, KFT ;
MCKAY, PJ ;
ROSENTHAL, KL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (11) :1321-1326
[4]   INTRARECTAL CHALLENGE OF MACAQUES VACCINATED WITH FORMALIN-INACTIVATED SIMIAN IMMUNODEFICIENCY VIRUS [J].
CRANAGE, MP ;
BASKERVILLE, A ;
ASHWORTH, LAE ;
DENNIS, M ;
COOK, N ;
SHARPE, S ;
FARRAR, G ;
ROSE, J ;
KITCHIN, PA ;
GREENAWAY, PJ .
LANCET, 1992, 339 (8788) :273-274
[5]   Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques [J].
Lehner, T ;
Wang, YF ;
Cranage, M ;
Bergmeier, LA ;
Mitchell, E ;
Tao, L ;
Hall, G ;
Dennis, M ;
Cook, N ;
Brookes, R ;
Klavinskis, L ;
Doyle, C ;
Ward, R .
NATURE MEDICINE, 1996, 2 (07) :767-775
[6]  
LOHMAN BL, 1995, J IMMUNOL, V155, P5855
[7]  
MARTHAS ML, 1992, VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P117
[8]  
Miller C. J., 1992, Laboratory Investigation, V68, P129
[9]  
MILLER CJ, 1992, J MED PRIMATOL, V21, P64
[10]   Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes [J].
Moore, JP ;
Cao, YZ ;
Leu, J ;
Qin, LM ;
Korber, B ;
Ho, DD .
JOURNAL OF VIROLOGY, 1996, 70 (01) :427-444